Kim, Dennis Dong Hwan. 2023. “Tyrosine Kinase Inhibitors for the Frontline Management of CML: An Overview”. Canadian Hematology Today 2 (1). Toronto, Canada:22–26. https://doi.org/10.58931/cht.2023.2124.